FBXO44 Antibodies

Santa Cruz Biotechnology offers a broad range of FBXO44 monoclonal antibodies for research focused on understanding FBXO44 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBXO44 is a member of the F-box protein family, which plays a vital role in the ubiquitin-proteasome pathway, a key mechanism for protein degradation and regulation within the cell. FBXO44 participates in cell cycle regulation and influences various cellular processes, making it essential for maintaining cellular homeostasis and function. Research has shown that FBXO44 may have significant implications in cancer development and progression. Scientists studying FBXO44 can gain valuable insights into cellular mechanisms and potential therapeutic targets. Understanding FBXO44 functions continues to reveal new possibilities in disease treatment and prevention. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FBXO44 and its role in human health and disease.